We have identified two distinct f-myosin heavy chains (MHCs) 
Introduction
The heart adapts to chronic pressure overload of the left ventricle (LV)' by concentric hypertrophy. Left ventricular hypertrophy is frequently caused by hypertension and may progress to a stage where contractile function diminishes, leading to end stage heart failure. Although changes in the mechanical behavior of hypertrophied ventricular muscles are well documented, the cellular and biochemical mechanisms that determine reduced intrinsic contractile performance remain poorly defined (1) .
Mechanical force in cardiac muscle is produced by the interdigitating movement of myosin and actin filaments. The transduction of chemical energy released by the hydrolysis of ATP into mechanical energy occurs at a site in the globular head of the myosin molecule. Myosin ATPase activity is known to be a major determinant of the velocity of shortening ofboth cardiac and skeletal muscle (2) . Native myosin exists as a hexameric molecule composed of two myosin heavy chains (MHCs) that contain the catalytic sites for ATP hydrolysis, and four lower molecular weight myosin light chains (3) . In small mammals (e.g., rats and rabbits) three isoforms of myosin, designated VI, V2, and V3 in order of decreasing electrophoretic mobility in nondenaturing gels and decreasing ATPase activity, have been identified in ventricular muscle (4) . The differences in electrophoretic mobility and catalytic activity of rat cardiac myosin isoforms result from the presence of two distinct types of MHCs, designated a-and p-chains, that exist in the native myosin molecule either as homodimers (V3 = 0,0 and VI = a,a) or as a heterodimeric molecule (V2 = a,#) (1) .
During cardiac adaptation to various developmental (5), hormonal (6) , and hemodynamic stimuli (7, 8) , the relative proportion of the two isoforms has been shown to change as the genes encoding the a-and f,-MHC are differentially expressed in response to such physiological conditions. The shifts in isoform expression towards increased levels of VI myosin in response to thyrotoxicosis (6) , and conversely towards increased levels of V3 myosin during pressure overload-induced hypertrophy (7, 8) , indicate that transcriptional regulation of MHCs is a fundamental determinant of cardiac mechanical behavior in smaller mammalian species.
In contrast to these species, larger mammals (e.g., dogs, pigs, and primates) express only a single myosin isoform orthologous to rat V3 myosin in ventricular muscle, despite similar cardiac mechanical alterations to hemodynamic and hormonal stimuli (1) . In particular, during concentric ventricular hypertrophy in response to pressure overload, no change in the native electrophoretic pattern of ventricular myosin in pyrophosphate gels has been detected despite evidence for a-to ,B-MHC transitions in the atria (9-1 1) (12) (13) (14) .
Methods
Baboon model of cardiac hypertrophy and hypertension. An experimental model ofcardiac hypertrophy and hypertension was developed in baboons (Papio sp.) using the one clip, two kidney Goldblatt or the bilateral perinephritis model (15) . From an initial population of 59 animals, 30 baboons were selected on the basis of the greatest extent and duration of hypertension and magnitude of left ventricular hypertrophy as determined by M mode echocardiography for use in a longitudinal study. The hearts of I I animals from this cohort were collected from planned necropsies or after natural attrition. Hearts of normotensive adult baboons from other terminal experiments conducted at the Southwest Foundation for Biomedical Research were used as control tissues for biochemical analyses. Each animal underwent a 2-3-wk period of conscious, systemic intraarterial BP monitoring before necropsy using methods previously described for this laboratory ( 16) .
Collection and processing oftissues. Baboon hearts were obtained at necropsy within an average of 1.6 (± 1.1 SD) h postmortem and immediately placed on wet ice. Each heart was dissected into five sections consisting ofleft and right atria, free wall regions ofthe left and right ventricles (RV), and the intraventricular septum (IVS). After removal of epicardial fat, each section of cardiac tissue was further subdivided into apex, midwall, and base regions and stored at -850C.
Preparation ofhomogenates and purification ofmyosin. The preparation of homogenates was performed generally as described by Hoh et al. (4) . Briefly, 50-mg samples from the midwall regions ofLV and RV and IVS were homogenized at 4VC with a tissumizer (Tekmar Co., Cincinnati, OH) in 100 mM tetrasodium pyrophosphate, pH 8.8, 5 mM Na4 EDTA, and 2 mM 2-mercaptoethanol. The homogenates were stirred at 40C for 2 h and centrifuged at 48,000 g for 2 h. Supernatants were stored at -20'C in 50% vol/vol glycerol in a final vol of 5 ml.
Myosin was isolated from midwall sections of myocardium from hypertensive and normal baboons in general according to the method ofPope et al. (17) with minor modifications. All purification steps were conducted in buffers containing a final concentration of 2 mM 2-mercaptoethanol, 20 .M leupeptin, and 10 kallikrein inhibitor units/ml of aprotinin. Aliquots were collected for analysis by SDS-PAGE at three stages during the purification process. The first aliquot was collected after initial homogenization of tissue and extraction with SDS-PAGE disruption buffer (see below); this aliquot contained the cytosolic, membrane, and most myofibrillar proteins that exist in heart muscle. The second aliquot was collected from the pellet resulting from three cycles of homogenization and centrifugation in low salt buffer (100 mM KCI, 50 mM Tris-HCI, pH 7.5); this aliquot contained a fraction of myocardial proteins enriched for myofibrillar constituents. The third aliquot was collected from the myosin preparation obtained after the sequential extraction ofinsoluble material from stage 2 in 600 mM KCl buffer, 50 mM Tris-HCl, pH 7.5, centrifugation at 40,000 g in the presence of 5 mM MgCI2 and 1 mM ATP, and dialysis against low salt buffer; this aliquot contained primarily myosin.
A TPase assays. Measurement of calcium-activated cardiac myosin ATPase activity was performed using the microATPase method of Henkel et al. (18) . Myosin used in these assays was isolated from l-g sections of LV from six hypertensive baboons and from five age-and sex-matched control (normotensive) animals as described above. All 11 myosin samples were purified and assayed for protein concentrations and ATPase activity as a single batch to Results A gradual onset model of chronic renal hypertension was developed in adult baboons (Papio sp.) using a one clip, two kidney Goldblatt or bilateral perinephritis wrap procedure. The mean conscious systemic arterial BP ofthe experimentally treated animals increased significantly (P < 0.01) by -60% from a normotensive value of 83±11 to 138±23 mmHg ( During this time a mean increase of 100% (P < 0.001) in the ratio of left ventricular mass to total body weight (BWT) occurred in 9 ofthe 11 animals. An increase of 1 1% (P < 0.01) in the right ventricular mass to BWT ratio and a 10% (P < 0.01) increase in the IVS mass to BWT ratio were observed in the hypertensive baboons compared with normotensive controls. The average LV/BWT ratio of hypertensive baboons was 4.99±1.53 compared with a value of2.54±0.26 determined for 11 normotensive male baboons maintained in an environment similar to that of the treated animals ( Fig. 1) . Average values for the RV/BWT and IVS/BWT ratios in hypertensive baboons (n 11) were 1.05±0.29 and 1.48±0.47, respectively, whereas respective values of 0.95±0.20 and 1.34±0.29 were observed for normotensive baboons (n = 82). Substantial left ventricular hypertrophy did not occur in two baboons in spite of significantly higher BPs in these animals. Analysis of native myosin isoforms was accomplished in pyrophosphate-buffered, nonrestrictive polyacrylamide gels using myosin extracted from cardiac myofibrils with 100 mM tetrasodium pyrophosphate. As represented in Fig. 2 , a single charge form of myosin was found in homogenates of LV myocardium from both hypertensive and normotensive animals. The same isoform pattern was observed in the RV and IVS from both cohorts of baboons (data not shown).
The calcium-activated ATPase activity of cardiac myosin in left ventricular myocardium from a subset of hypertensive baboons was determined for comparison with that from a group of normotensive animals. As shown in Table I , myosin ATPase activity from hypertensive baboons was determined to be 0.181 gmol of inorganic phosphate released/min per mg myosin. This value was significantly lower (P < 0.05) than the average value of 0.273 gmol of inorganic phosphate released/ min per mg of myosin determined for myosin ATPase activity from control animals.
Cardiac myosin from hypertensive and normal baboons was further analyzed after denaturation into heavy and light chain components by SDS-PAGE in gradient pore gels. As seen in Fig. 3 , left ventricular myocardium from two hypertensive baboons (animal numbers X2296 and X3 156) and one normotensive animal (X2961) contained a 210-kD polypeptide in cardiac homogenates (sample 1), in a fraction enriched for myofibrillar proteins (sample 2), and in partially purified preparations of myosin (sample 3). This polypeptide was tentatively identified as MHC based on previous reports (3). An additional polypeptide with an estimated molecular mass of 200 kD was observed at increased levels in SDS-PAGE polypeptide profiles of hypertensive baboon left ventricular myocardium. A trace amount of this 200-kD polypeptide was found in most but not all of the LVs of control animals. The 200-kD polypeptide copurified with the 2 10-kD MHC in samples collected from hypertensive animals.
The immunochemical properties of the 200-kD polypeptide found in increased levels in hypertensive baboon LVs and the normal 2 10-kD MHC were examined in Western blotting experiments using MAbs that had been raised against human myosin and were specific for several distinct MHC epitopes. In these experiments, MHCs in cardiac muscle homogenized in 100 mM tetrasodium pyrophosphate were immunoperoxidase (Fig. 5) , whereas average (2 MHC values of < 6%±5 were detected in all normal samples and in the RV and IVS of hypertensive animals (P < 0.001). Representative experimental results from the electrophoretic survey are shown in Fig. 6 . SDS-PAGE polypeptide profiles from normal hearts shown in Fig. 6 include two animals (Xl931 and X3300) with (2 MHC levels representative of the normotensive cohort average and one animal with the highest and one with the lowest (32 MHC values in the normotensive group (X2094 and X3580, respectively). Profiles shown for the hypertensive baboons include an animal with (32 MHC levels near the mean of the hypertensive group (X3156), two animals with the highest levels of (32 MHCs (X 1829 and X 1 184), and the single hypertensive (X 1643) animal in the group with normal levels of(2 MHCs similar to the mean value of the normotensive group.
The associations between LV/BWT and mean arterial BP and between LV/BWT and the level of (2 MHC were determined by least squares linear regression analysis. A correlation coefficient (r) of 0.51 and a significance level of the regression (P < 0.062) were determined for the relationship between LV/ BWT and mean arterial BP. An r value of0.55 (P . 0.009) was observed between LV/BWT and the level of (2 MHC in baboons. Considerable variation was observed in the distribution of(2 MHCs in the LV of hypertensive baboons. The variance
of the hypertensive group of baboons with respect to the level of fl-MHCs was greater than that of the normotensive cohort (P < 0.005). There was also greater variability in the hypertensive baboons in the distribution of BPs (P < 0.02) and left ventricular hypertrophy (P < 0.0001).
Discussion
We (Table I) . It has been well documented that the different catalytic properties of cardiac a-and /3-MHCs account for the disparate shortening velocities of muscles containing each type of MHC (1, 2) . The differential expression of a-and /3-MHCs in the hearts of small mammals and in the atria of large animals serves as a mechanism for cardiac adaptation to changes in hemodynamic load (7, 8) , hormonal stimulation (6), and developmental programs (5) . The same type ofadaptive mechanism, however, has not been observed in ventricular myocardium of large mammals. Although low levels of a-MHCs have been detected in human ventricles by several investigators using immunological techniques (29, 30) , others report the exclusive expression of /3-MHCs in these tissues (31) . In any case, /3-type chains have been shown to be the predominant form of MHC found in ventricular muscle of large animals regardless of the physiologic environment (1) .
Some evidence suggesting the existence of more than one type of /3-MHC in ventricles of large mammals has been obtained using biochemical (32) and immunological techniques (10, 33) ; however, these studies did not detect differences in the molecular weights of /3-MHCs such as those that we have observed in hypertensive baboon ventricles. None of the studies which have presented evidence of /3-MHC heterogeneity, including our own, have determined the origin of the structural variation in these proteins. Four (35) . Although the molecular weight variation that we observed in ,B-MHCs from hypertrophied ventricular myocardium has not been reported previously, differences of the same magnitude between molecular weights of MHCs seen in our experiments have been detected in skeletal muscle myosins. Rushbrook and Stracher (36) reported molecular weight heterogeneity in MHCs from skeletal muscle using 5% acrylamide SDS gels. Umeda et al. (37) established that these MHC isoforms were not the result of proteolytic processes by demonstrating the existence of distinct mRNAs coding for fast and slow MHCs in a cell-free translation system. Other studies have confirmed the existence of multiple MHC isoforms in skeletal muscle (38 
